814 results on '"Przybilla, Bernhard"'
Search Results
2. IgE-mediated wheat allergy presenting with the clinical picture of chronic urticaria
3. Naturlatexallergie — ein Ernstes Risiko
4. S2k guideline on diagnosis and treatment of atopic dermatitis — short version
5. Fortschritte in der Allergiediagnostik
6. Toxische und allergische Kontaktdermatitis
7. Tryptases, a Marker of Occult Mastocytosis
8. Insektengiftanaphylaxie: Ein gelöstes Problem?
9. Naturlatexallergie vom Soforttyp
10. Diagnostik und Therapie von Nahrungsmittelallergien
11. Bienen- und Wespengiftallergie
12. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)
13. Hyposensibilisierung
14. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG
15. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB)
16. S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion
17. Das schwere atopische Ekzem: Diagnostik und Therapie
18. Tryptase, ein Marker für okkulte Mastozytose
19. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase †
20. Lichttherapie des atopischen Ekzems
21. Schnelles Handeln erhält den Arbeitsplatz: Berufsbedingte Erkrankungen der Haut
22. Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015
23. Allergologische Kasuistiken – Fälle und Fallen
24. Spezifische Immuntherapie – Hyposensibilisierung
25. Photoallergisches Kontaktekzem auf Pirfenidon (Esbriet®)
26. Changes in intracellular cyclic adenosine monophosphate levels in peripheral blood leukocytes during immunotherapy with vespid venom
27. Erkrankungen durch Bienen- und Wespenstiche
28. Toxische und allergische Kontaktdermatitis
29. Contact Dermatitis
30. Kofaktorabhängige Nahrungsmittelanaphylaxie bei Porc-chat-Syndrom
31. Nahrungsmittelallergie
32. Spezifische Immuntherapie/Hyposensibilisierung
33. Der Allergie-Diagnostik mit dem Epikutantest droht das Aus Gemeinsame Stellungnahme zur Novellierung des Arzneimittelgesetzes der DDG, DGAKI, DKG, ABD, BVDD, ÄDA, GPA, DGAUM und des IVDK*
34. Tryptase, ein Marker für die Aktivierung und Lokalisation von Mastzellen
35. Rund um Arzneimittelüberempfindlichkeiten
36. Systembeteiligung bei Urticaria pigmentosa
37. Lebensbedrohende Anaphylaxie
38. Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors?
39. Hymenopterengiftallergie
40. Hymenoptera venom allergy
41. Retraction Note To: Dia-Klinik
42. Retracted Chapter: Arzneiexanthem auf Etofibrat
43. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase—a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity
44. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy
45. Neurodermitis S2-Leitlinie
46. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy
47. Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel
48. Allergological approach to drug hypersensitivity reactions
49. Comparative analysis of the phototoxicity induced by BRAF inhibitors and alleviation through antioxidants
50. Retracted Chapter: Allergisches Kontaktekzem nach Henna-„Tätowierung“
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.